Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials

Po-Yueh Chen¹, Feng-Pai Tsai², Mei-Jyh Chen^{3

4}, Hsin-Yi Yang⁵, Ming-Shiang Wu^{3

4}, Jyh-Ming Liou^{6

4

7}

Affiliations

¹ Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan.
² Departments of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
³ Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
⁴ Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
⁵ Clinial Data Center, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan.
⁶ Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan jyhmingliou@gmail.com.
⁷ Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.

PMID: 37001979
DOI: 10.1136/gutjnl-2023-329826

Comment

Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials

Po-Yueh Chen et al. Gut. 2024.

. 2024 Apr 5;73(5):872-874.

doi: 10.1136/gutjnl-2023-329826.

Authors

Po-Yueh Chen¹, Feng-Pai Tsai², Mei-Jyh Chen^{3

4}, Hsin-Yi Yang⁵, Ming-Shiang Wu^{3

4}, Jyh-Ming Liou^{6

4

7}

Affiliations

¹ Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan.
² Departments of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
³ Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
⁴ Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
⁵ Clinial Data Center, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan.
⁶ Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan jyhmingliou@gmail.com.
⁷ Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.

PMID: 37001979
DOI: 10.1136/gutjnl-2023-329826

No abstract available

Keywords: HELICOBACTER PYLORI - TREATMENT; META-ANALYSIS.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report.
Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M, O'Morain C, Rugge M, Suerbaum S, Tilg H, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study group. Malfertheiner P, et al. Gut. 2022 Aug 8:gutjnl-2022-327745. doi: 10.1136/gutjnl-2022-327745. Online ahead of print. Gut. 2022. PMID: 35944925

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials

Affiliations

Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical